| Intravenous arketamine for treatment-resistant depression: open-label pilot study GC Leal, ID Bandeira, FS Correia-Melo, M Telles, RP Mello, F Vieira, ... European archives of psychiatry and clinical neuroscience 271, 577-582, 2021 | 190 | 2021 |
| Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: a randomized, double-blind, non-inferiority study FS Correia-Melo, GC Leal, F Vieira, AP Jesus-Nunes, RP Mello, ... Journal of affective disorders 264, 527-534, 2020 | 151 | 2020 |
| Comparative study of esketamine and racemic ketamine in treatment-resistant depression: protocol for a non-inferiority clinical trial FS Correia-Melo, GC Leal, MS Carvalho, AP Jesus-Nunes, CBN Ferreira, ... Medicine 97 (38), e12414, 2018 | 57 | 2018 |
| Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review FS Correia-Melo, FC Argolo, L Araújo-de-Freitas, GC Leal, F Kapczinski, ... Neuropsychiatric disease and treatment, 1627-1632, 2017 | 41 | 2017 |
| Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: a comparative, randomized and double-blind study L Araújo-de-Freitas, C Santos-Lima, E Mendonça-Filho, F Vieira, ... Psychiatry Research 303, 114058, 2021 | 23 | 2021 |
| Ketamine and Esketamine augmentation for suicidal ideation: a randomized, double-blinded clinical trial F Vieira, FS Correia-Melo, C Santos-Lima, B Souza-Marques, GC Leal, ... General hospital psychiatry 68, 97-99, 2021 | 18 | 2021 |
| Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study GC Leal, B Souza-Marques, RP Mello, ID Bandeira, AT Caliman-Fontes, ... Journal of Affective Disorders 330, 7-15, 2023 | 17 | 2023 |
| Ketamine in the treatment of obsessive-compulsive disorder: a systematic review ID Bandeira, DH Lins-Silva, VB Cavenaghi, I Dorea-Bandeira, ... Harvard review of psychiatry 30 (2), 135-145, 2022 | 15 | 2022 |
| Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: secondary analysis from a randomized controlled trial RP Mello, MVF Echegaray, AP Jesus-Nunes, GC Leal, GM Magnavita, ... Journal of Psychiatric Research 138, 576-583, 2021 | 15 | 2021 |
| Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression AP Jesus‐Nunes, GC Leal, FS Correia‐Melo, F Vieira, RP Mello, ... Human Psychopharmacology: Clinical and Experimental 37 (4), e2836, 2022 | 13 | 2022 |
| Arketamine for bipolar depression: open-label, dose-escalation, pilot study ID Bandeira, GC Leal, FS Correia-Melo, B Souza-Marques, SS Silva, ... Journal of Psychiatric Research 164, 229-234, 2023 | 8 | 2023 |
| Encuesta de crecimiento, desarrollo y salud materna en Canelones I Bove, M Napol, D Curbelo, G Leal Encuesta de crecimiento, desarrollo y salud materna en Canelones, 103-103, 2012 | 8 | 2012 |
| Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial AT Caliman-Fontes, GC Leal, FS Correia-Melo, CS Paixao, MS Carvalho, ... Trends in Psychiatry and Psychotherapy 45, 2023 | 6 | 2023 |
| Esketamine for unipolar major depression with psychotic features: a retrospective chart review and comparison with nonpsychotic depression B Souza-Marques, M Telles, GC Leal, D Faria-Guimarães, ... Journal of Clinical Psychopharmacology 42 (4), 408-412, 2022 | 6 | 2022 |
| Letter to the Editor: Antidepressant and Antisuicidal Effects of Esketamine in Adolescents with Major Depressive Disorder and Suicidal Ideation: A Case Series D Faria-Guimarães, F Vieira, B Souza-Marques, SS Silva, ID Bandeira, ... Journal of Child and Adolescent Psychopharmacology 32 (6), 366-367, 2022 | 5 | 2022 |
| Suicide attempt, impulsivity, and exposure to trauma in college students SB Lira, F Vieira, DE Cavalcanti, B Souza-Marques, LR Netto, ... Brazilian Journal of Psychiatry 44, 279-288, 2022 | 4 | 2022 |
| Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine and esketamine in treatment-resistant depression? A secondary … AT Caliman-Fontes, M Telles, LNF Guerreiro-Costa, RF Marback, ... Trends in Psychiatry and Psychotherapy, 0-0, 2023 | 1 | 2023 |
| Effects of GRIN2B, GRIA1, and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a … G Beanes, AT Caliman-Fontes, B Souza-Marques, HDS Silva, GC Leal, ... Clinical Neuropharmacology 45 (6), 151-156, 2022 | 1 | 2022 |
| Neurogenic Pulmonary Edema After Electroconvulsive Therapy in 2 Young Patients LR Oliva, MFL Santos, GCG Leal The Journal of ECT 38 (2), e20-e21, 2022 | 1 | 2022 |
| MicroRNAs as diagnostic biomarkers and predictors of antidepressant response in major depressive disorder: a systematic review. Running title: miRNAs as biomarkers of MDD BA Carneiro, LNF Guerreiro-Costa, DH Lins-Silva, D Faria-Guimarães, ... medRxiv, 2024.02. 17.24302977, 2024 | | 2024 |
